AHAS inhibitor is a novel acetohydroxyacid synthase(AHAS) inhibitor, a promising drug target against Mycobacterium tuberculosis (MTB).
- Country: China (Mainland)
- Market: European Union,Americas
- Founded Year: 2009
- Address: 武汉东湖高新区长城科技园光谷精工D栋402室
- Contact: Rosie Liu